Baldry Mark
- SEC CIK
- 0001644137
No open-market purchases or sales filed in the past year.
Current role at each company
- XFOR X4 Pharmaceuticals, IncChief Commercial Officeras of Jun 3, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Baldry Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 (view filing)4:08 PM ET | May 17-Nov 15, 2024 | 273 daysLate | Baldry MarkChief Commercial Officer | PPurchase | +35.0K | $0.5493 | +$19.3K | +37.2%129.2K after | 2 lots |
| Jan 27, 2025 (view filing)6:15 PM ET | Jan 24 | 3 days | Baldry MarkChief Commercial Officer | SSale | −29.2K | $0.4541 | −$13.2K | −23.7%94.1K after | |
| Oct 8, 2024 (view filing) | Oct 7 | 1 day | Baldry MarkChief Commercial Officer | SSale | −11.1K | $0.58 | −$6.45K | −18.7%48.5K after | |
| Nov 3, 2023 (view filing) | Nov 1 | 2 days | Baldry MarkChief Commercial Officer | SSale | −10.3K | $0.73 | −$7.49K | −29.4%24.7K after | 10b5-1 |